The current earnings forecast score of Fresenius Medical Care AG is 4.67, ranking 66 out of 74 in the Healthcare Providers & Services industry. The average price target is 28.00, with a high of 39.65 and a low of 20.70.
Analyst Rating
Based on
6
analysts
Sell
Current Rating
21.118
Target Price
-13.27%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
59
Total
9
Median
10
Average
Company name
Ratings
Analysts
Fresenius Medical Care AG
FMS
6
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
26
Teladoc Health Inc
TDOC
25
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Fresenius Medical Care AG's expected revenue for the next quarter?
Fresenius Medical Care AG's expected revenue is 5.66B.
What is Fresenius Medical Care AG's price target?
Analysts forecast that Fresenius Medical Care AG's price target is USD 28.00, with the highest forecast at USD 39.65 and the lowest forecast at USD 20.70.
How have Fresenius Medical Care AGFMS's recent earnings per share performed?
The market expectation was USD 0.47, while Fresenius Medical Care AGFMS's earnings per share (EPS) for the previous quarter was USD 0.25. EPS for the next quarter is expected at USD 0.61.
What is the analyst rating for Fresenius Medical Care AG?
Based on the ratings of Fresenius Medical Care AG's stock from 6 analysts, most analysts support a Sell trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Sell. Please note that this is not trading advice. You still need to conduct your own analysis.